XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2025
Stock-Based Compensation  
Stock-Based Compensation

10.Stock-Based Compensation

Stock Option Activity

A summary of the Company’s stock option activity and related information follows:

Weighted

Average

Weighted-

Remaining

Aggregate

Average

Contractual

Intrinsic Value

    

Shares

    

Exercise Price

    

Term (years)

    

(in thousands)

Outstanding at December 31, 2024

 

6,850,889

$

13.75

 

8.31

$

2,946

Granted

 

4,450,300

$

6.53

Cancelled or forfeited

 

(74,905)

$

9.97

Expired

(473)

$

682.65

Outstanding at June 30, 2025

11,225,811

$

10.89

8.56

$

447

Vested and exercisable at June 30, 2025

3,570,804

$

14.39

7.22

$

302

Vested and expected to vest at June 30, 2025

 

11,225,811

$

10.89

8.56

$

447

There were no options exercised during the three and six months ended June 30, 2025. The intrinsic value of stock options exercised during the three and six months ended June 30, 2024 was $0.1 million and $0.2 million, respectively. The total grant date fair value of stock options vested for the three and six months ended June 30, 2025 was $3.9 million and $12.2 million, respectively. The total grant date fair value of stock options vested for the three and six months ended June 30, 2024 was $2.5 million and $5.6 million, respectively. The weighted-average grant date fair value per share of options granted for the three and six months ended June 30, 2025 was $3.75 and $4.56, respectively. The weighted-average grant date fair value per share of options granted for the three and six months ended June 30, 2024 was $6.64 and $9.95, respectively.

As of June 30, 2025, the total unrecognized compensation expense related to unvested stock option awards was $44.8 million. The Company expects to recognize that cost over a weighted-average period of approximately 2.8 years.

Stock-Based Compensation Expense

During the three and six months ended June 30, 2025 and 2024, the Company recorded stock-based compensation expense for employee and non-employee stock options and restricted stock, which was allocated as follows in the statements of operations (in thousands):

Three Months Ended June 30,

Six Months Ended June 30,

    

2025

    

2024

    

2025

    

2024

General and administrative

$

2,729

$

2,531

$

5,266

$

4,581

Research and development

1,622

920

 

2,924

 

1,624

Total

$

4,351

$

3,451

$

8,190

$

6,205

No related tax benefits were recognized during the three and six months ended June 30, 2025 and 2024.